Gut microbiota-derived imidazole propionate is a novel marker of cardiometabolic risk in patients with coronary artery disease

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Pathophysiology in acute coronary syndromes (1) Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by